Better Obesity Drug Race: Novo Nordisk vs Lilly 2026
In the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
A focused look at volatility by index, comparing metrics like daily ranges and swing intensity to help you benchmark market behavior.
19,819 articlesIn the race to dominate obesity drugs, Novo Nordisk and Eli Lilly are frontrunners. This guide analyzes who has the e...
A new survey of large U.S. companies finds finance leaders divided they'd on how to use tariff refunds, with only a m...
A year after taking the helm at Stellantis, Antonio Filosa faces a mixed bag: a Q1 2026 earnings beat, a historic 202...
Carrier Global reports a 400% surge in North American data center orders in Q4, signaling a rapid shift toward AI inf...
A Dream Finders insider sale grabbed attention after the stock dropped nearly 30%. This guide breaks down what know a...
Andreessen Horowitz’s crypto arm is raising its fifth fund, aiming about $2 billion with a close planned for mid-2026...
Thinking about leaving the workforce earlier than planned? These five practical signals can help you spot when you ma...
An emerging critical iPhone exploit targets crypto apps as Morgan Stanley moves to shore up Bitcoin infrastructure wi...
Ripple wins preliminary approval to operate under MiCA in Luxembourg, but the path to a full MiCA license is far from...
Greg Abel, two months into his role as Berkshire Hathaway CEO, commits to using his after-tax salary to buy Berkshire...
Analysts say Bitcoin’s price cycles show a repeatable cadence. With a high in October 2025 and a window around Octobe...
As Baidu surges, a hedge fund’s multi-million bet raises questions about AI, China’s digital economy, and portfolio c...